scholarly journals Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial

2007 ◽  
Vol 2 (5) ◽  
pp. e27 ◽  
Author(s):  
Leigh Peterson ◽  
Doug Taylor ◽  
Ronald Roddy ◽  
Ghiorghis Belai ◽  
Pamela Phillips ◽  
...  
Keyword(s):  
Hiv Infection ◽  
Tenofovir Disoproxil Fumarate ◽  
Controlled Trial ◽  
Phase 2 ◽  
Double Blind ◽  
Prevention Of Hiv

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

The Lancet ◽  
2008 ◽  
Vol 372 (9654) ◽  
pp. 1977-1987 ◽  
Author(s):  
Stephanie Skoler-Karpoff ◽  
Gita Ramjee ◽  
Khatija Ahmed ◽  
Lydia Altini ◽  
Marlena Gehret Plagianos ◽  
...  
Keyword(s):  
South Africa ◽  
Hiv Infection ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Prevention Of Hiv

scholarly journals SAVVY® (C31G) Gel for Prevention of HIV infection in Women: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Ghana

PLoS ONE ◽  
2007 ◽  
Vol 2 (12) ◽  
pp. e1312 ◽  
Author(s):  
Leigh Peterson ◽  
Kavita Nanda ◽  
Baafuor Kofi Opoku ◽  
William Kwabena Ampofo ◽  
Margaret Owusu-Amoako ◽  
...  
Keyword(s):  
Hiv Infection ◽  
Controlled Trial ◽  
Phase 3 ◽  
Double Blind ◽  
Prevention Of Hiv

scholarly journals Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: A phase 2, randomised, double-blind, placebo controlled trial

Maturitas ◽  
2017 ◽  
Vol 100 ◽  
pp. 142-143
Author(s):  
Julia Prague ◽  
Rachel Roberts ◽  
Alexander Comninos ◽  
Sophie Clarke ◽  
Channa Jayasena ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Hot Flushes ◽  
Phase 2 ◽  
Double Blind ◽  
Receptor Antagonism ◽  
Double Blind Placebo ◽  
Novel Treatment ◽  
Neurokinin 3 Receptor
Sign in / Sign up

Export Citation Format

Share Document